Jonathan G. Drachman
Equibles does not estimate personal net worth.
About Jonathan G. Drachman
Earlier roles on record: CEO and Board Member at Neurogene Inc. (NGNE) until March 31, 2023. Neurogene Inc. reported in an 8-K filed March 10, 2023 that Jonathan G. Drachman resigned as director, effective March 31, 2023. Neurogene Inc. reported in an 8-K filed March 10, 2023 that Jonathan G. Drachman resigned as President, Chief Executive Officer, principal executive and financial officer, effective March 31, 2023. The proxy statement of Neurogene Inc. reports total compensation of $549,983 for Jonathan G. Drachman in fiscal 2023, including a base salary of $113,544. Disclosed compensation is on record for 3 fiscal years.
“Jonathan G. Drachman, M.D. will be resigning from his role as President, Chief Executive Officer, principal executive and financial officer, and will also be resigning as a director of the Company, all effective March 31, 2023 ("Separation Date").”
“Jonathan G. Drachman, M.D. will be resigning from his role as President, Chief Executive Officer, principal executive and financial officer, and will also be resigning as a director of the Company, all effective March 31, 2023 ("Separation Date").”
Affiliation history
-
2019-01-01–2023-03-31
-
Start not stated–2023-03-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Neurogene Inc. (NGNE) | Former Chief Executive Officer and President | $113,544 | $549,983 |
| 2022 | Neurogene Inc. (NGNE) | Former Chief Executive Officer and President | $452,985 | $902,179 |
| 2019 | Neurogene Inc. (NGNE) | Chief Executive Officer | $137,304 | $3,823,038 |